Category: Stock NewsHome

Stock News

stock news

Tricida Stock | TCDA News, Quotes, Targets for 2023 – 2030
thumbnail
by Cavix   ·  November 30, 2022   ·  
no comment

Tricida, Inc. is a pharmaceutical business. It concentrates on the development and marketing of veverimer (TRC101), an orally administered, non-absorbed polymer that has successfully completed a Phase III trial to treat respiratory acidosis in patients suffering from chronic renal disease by eliminating acid first from gastrointestinal tract. The business was established in 2013 and has its ...

Airbus Stock Forecasts, Quotes, News: 2023, 2024, 2025, 2030
thumbnail
by Cavix   ·  November 29, 2022   ·  
no comment

A multinational aerospace company based in Europe is called Airbus. Airbus builds planes in Europe and several other nations in addition to designing, producing, and marketing civil and military aviation products globally. The corporation is divided into three segments Commercial Aircraft (Airbus S.A.S.), Defense and Space, and Helicopters. The third segment, measured by revenues and turbine ...

Planet 13 Stock Forecast News, Targets, Quotes – 2023 – 2030
thumbnail
by Cavix   ·  November 28, 2022   ·  
no comment

With award-winning operations in cultivation, production, and dispensaries in Las Vegas and Orange County, California, Planet 13 is a vertical integration cannabis corporation. Additionally, Planet 13 has a license to operate a medical marijuana psychiatric hospital in Florida and owns a 49% stake in Planet 13 Illinois, which just won a lottery to operate a social-equity ...

COSM Stock Forecast, News, and Targets
thumbnail
by Cavix   ·  November 25, 2022   ·  
no comment

Pharmaceutical company Cosmos Holdings Inc. is vertically integrated. Through its distribution networks and an online store, it provides an unique line of branded and generic medicines, nutraceuticals, over-the-counter medicines, health and baby goods, medical gadgets. And other products. The business also runs a warehouse facility and has distribution network in Greece and the UK. It finds, ...

ARDX Stock Forecast 2023, 2024, 2025, 2030
thumbnail
by Cavix   ·  November 24, 2022   ·  
no comment

A biopharmaceutical business called Ardelyx, Inc. finds, creates, and sells drugs for digestive and cardiorenal therapeutic categories both domestically and abroad. Tenapanor, the company's leading product candidate, has successfully completed a Phase II clinical court case. For the treatment of individuals with constipation-related irritable bowel syndrome. And is currently undergoing a Phase II clinical trial to ...